Your browser doesn't support javascript.
loading
Medication-induced SIADH: distribution and characterization according to medication class.
Shepshelovich, Daniel; Schechter, Amir; Calvarysky, Bronislava; Diker-Cohen, Talia; Rozen-Zvi, Benaya; Gafter-Gvili, Anat.
Afiliação
  • Shepshelovich D; Medicine A, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
  • Schechter A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Calvarysky B; Medicine A, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
  • Diker-Cohen T; Medicine A, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
  • Rozen-Zvi B; Pharmacy Service, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
  • Gafter-Gvili A; School of Pharmacy, the Faculty of Medicine, Hebrew University, Jerusalem, Israel.
Br J Clin Pharmacol ; 83(8): 1801-1807, 2017 08.
Article em En | MEDLINE | ID: mdl-28168757
AIMS: The aims of the current study were to determine the distribution of aetiologies for the drug-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) in hospitalized patients, and to characterize them according to the different drug groups. METHODS: A single-centre retrospective study was carried out, including all patients diagnosed with SIADH in a large community hospital and tertiary centre between 1 January 2007 and 1 January 2013 who were treated with drugs known to be associated with SIADH. Two physicians reviewed every patient's medical file for predetermined relevant clinical data. RESULTS: The study cohort included 198 patients who had SIADH and received drugs associated with SIADH. Most patients [146 (73.7%)] were diagnosed with drug-associated SIADH, while 52 (26.3%) were diagnosed with SIADH due to other aetiologies. The Naranjo algorithm differentiated well between the two groups (P < 0.001). Five drug classes (antidepressants, anticonvulsants, antipsychotic agents, cytotoxic agents and pain medications) were implicated in 82.3% of patients diagnosed with drug-associated SIADH. Specific serotonin reuptake inhibitors and carbamazepine were commonly implicated. There were no clinically significant differences in the characteristics or severity of SIADH according to drug class. CONCLUSIONS: The clinical characteristics of SIADH caused by different drugs are comparable. Patients with SIADH treated with drugs from five common medication classes will probably be diagnosed with drug-induced SIADH. Physicians should be aware of the significance of these medication classes as SIADH aetiologies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carbamazepina / Inibidores Seletivos de Recaptação de Serotonina / Hiponatremia / Síndrome de Secreção Inadequada de HAD Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carbamazepina / Inibidores Seletivos de Recaptação de Serotonina / Hiponatremia / Síndrome de Secreção Inadequada de HAD Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Israel